Tweedy Browne Co. Ligand Pharmaceuticals Inc Put Options Transaction History
Tweedy, Browne CO LLC
- $1.01 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
284Shares Held
18.9MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$420 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$301 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$150 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$133 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$109 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.47B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...